681490-93-7

Basic information

• Product Name: DE-7
• Synonyms: DE-7;(R)-2-chloro-1-{(2-methyloxiran-2-yl)methyl}-4-nitro-1H-imidazole;2-Chloro-1-[[(2R)-2-methyloxiranyl]methyl]-4-nitro-1H-imidazole
• CAS NO: 681490-93-7
• Molecular Formula: C₇H₈ClN₃O₃
• Molecular Weight: 217.60972
• EINECS: -0
• Mol File: 681490-93-7.mol
• Article Data: 5

Chemical Properties

• Melting Point: 72-73 °C
• Boiling Point: 393.9±38.0 °C(Predicted)
• Appearance: /
• Density: 1.68±0.1 g/cm3(Predicted)
• Solubility: Chloroform, DCM
• PKA: -2.55±0.60(Predicted)
• CAS DataBase Reference: DE-7(CAS DataBase Reference)
• NIST Chemistry Reference: DE-7(681490-93-7)
• EPA Substance Registry System: DE-7(681490-93-7)

Safety Data

• Hazardous Substances Data: 681490-93-7(Hazardous Substances Data)

Usage

Description

DE-7, also known as 2-Chloro-1-[[(2R)-2-methyloxiranyl]methyl]-4-nitro-1H-imidazole, is an intermediate in the synthesis of Delamanid (D230660), a novel anti-tuberculosis medication. It plays a crucial role in inhibiting mycolic acid synthesis, which is essential for the growth and survival of Mycobacterium tuberculosis, the causative agent of tuberculosis.
Used in Pharmaceutical Industry:
DE-7 is used as an intermediate in the synthesis of Delamanid (D230660) for its potent in-vitro and in-vivo activity against drug-resistant strains of Mycobacterium tuberculosis. This makes it a valuable component in the development of new anti-tuberculosis medications to combat the growing issue of drug resistance in tuberculosis treatment.

Upstream product

• 681490-92-6 (R)-3-(2-chloro-4-nitro-1H-imidazol-1-yl)-2-hydroxy-2-methylpropylmethanesulfonate 
• 681490-91-5 (R)-2-chloro-1-(2,3-dihydroxy-2-methyl)-propyl-4-nitroimidazole 
• 681490-95-9 (R)-2-chloro-1-[2-hydroxy-2-methyl-3-(4-nitrobenzoyloxy)]-propyl-4-nitroimidazole 
• 683276-63-3 [(2S)-2-methyloxiran-2-yl]methyl 4-nitrobenzene-1-sulfonate 
• 57531-37-0 2-chloro-4-nitro-1H-imidazole 

Downstream Products

• 681492-18-2 2-methyl-6-nitro-2-(4-thiomorpholin-4-yl-phenoxymethyl)-2,3-dihydro-imidazo[2,1-b]oxazole 
• 681032-13-3 (S)-1-(2-chloro-4-nitroimidazol-1-yl)-2-methyl-3-[4-(4-trifluoromethoxyphenyl)piperazin-1-yl]propan-2-ol 
• 1351281-10-1 (R)-2-((4-fluorophenoxy)methyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole 

Relevant articles and documents

ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE

Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.

6-NITRO-2,3-DIHYDROIMIDAZO[2,1-b]OXAZOLES AND A PROCESS FOR THE PREPARATION THEREOF

The present invention relates to newer generation of triazoles, tetrazoles, isoxazoles, urea and sulphonamide functionalities containing 6-nitro-2, 3-dihydronitroimidazooxazoles agents of formula 1, their method of preparation, and their use as drugs for

1-SUBSTITUTED 4-NITROIMIDAZOLE COMPOUND AND PROCESS FOR PRODUCING THE SAME

The present invention relates to a 1-substituted-4-nitroimidazole compound represented by the general formula (1) or a salt thereof, (wherein R is a hydrogen atom, a lower alkoxy group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a cyano-substituted lower alkyl group, a phenyl-lower alkyl group which may have lower alkoxy groups as the substituents in the phenyl ring or a group of the formula -CH2RA; X is a halogen atom or a group of the formula -S(O)n-R1) and method for preparing the same. The compound of the formula (1) is a useful compound as an intermediate for synthesis of various pharmaceutical and agricultural chemicals, particularly, as intermediates for antitubercular agents.